MMS.NYSEMaximus, INC

8-K: Maximus Raises Earnings Outlook, Announces $400M Share Buyback

Sentiment:

Quarterly Results


Maximus reported strong fiscal second quarter 2026 results, exceeding expectations and leading to an increased full-year earnings outlook and a refreshed $400 million share repurchase program.

Better than expectedThe company raised its full-year adjusted EBITDA margin expectation by 20 basis points to approximately 14.2%.The company raised its full-year adjusted diluted earnings per share expectation by $0.20 to range between $8.25 and $8.55 per share.Diluted earnings per share increased to $1.80 from $1.69 year-over-year.Adjusted diluted earnings per share increased to $2.07 from $2.01 year-over-year.U.S. Federal Services segment operating margin improved to 17.6% from 15.3% year-over-year, driven by technology initiatives.Adjusted EBITDA margin improved to 14.4% from 13.7% year-over-year.

Summary

  • Maximus announced its financial results for the second quarter of fiscal year 2026, ending March 31, 2026.
  • Revenue for the quarter was $1.31 billion, consistent with expectations and a slight decrease from $1.36 billion in the prior year period, which benefited from natural disaster support and temporary clinical volume surges.
  • Diluted earnings per share (EPS) were $1.80, an increase from $1.69 in the prior year period, with adjusted diluted EPS at $2.07, up from $2.01.
  • The company is raising its full-year fiscal 2026 adjusted EBITDA margin expectation by 20 basis points to approximately 14.2% and increasing its adjusted diluted EPS guidance by $0.20 to a range of $8.25 to $8.55 per share.
  • Revenue and free cash flow guidance for the full fiscal year 2026 remain unchanged.
  • Maximus repurchased 1.4 million shares for $111 million in the quarter and an additional 0.6 million shares for $39.9 million through May 1, 2026.
  • The Board of Directors authorized a refreshed share repurchase program of up to $400 million, effective May 11, 2026.
  • A quarterly cash dividend of $0.33 per share will be paid on June 1, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report due to the raised earnings outlook and significant share repurchase authorization, despite a slight revenue dip year-over-year.

Positives

  • Raised full-year adjusted EBITDA margin guidance by 20 basis points to approximately 14.2%.
  • Increased full-year adjusted diluted EPS guidance by $0.20 to a range of $8.25 to $8.55 per share.
  • Second consecutive quarter of earnings guidance increase, reflecting confidence in leveraging AI and technology for efficiency and margin expansion.
  • Operating margin improved to 11.4% from 11.2% in the prior year period.
  • Adjusted EBITDA margin increased to 14.4% from 13.7% in the prior year period.
  • U.S. Federal Services segment operating margin improved significantly to 17.6% from 15.3% due to technology initiatives and automation.
  • Repurchased $111 million of common stock in the quarter and an additional $39.9 million through May 1, 2026.
  • Authorized a new $400 million share repurchase program.

Negatives

  • Revenue decreased to $1.31 billion from $1.36 billion in the prior year period, primarily due to the absence of natural disaster support work and temporary clinical volume surges.
  • U.S. Services segment revenue was $416 million, down from $442 million in the prior year period.
  • U.S. Services segment operating margin was 9.3% (10.9% excluding impairment charge), down from 12.2% in the prior year period.
  • Outside the U.S. Segment reported an operating loss of $3.1 million, compared to an operating profit of $4.8 million in the prior year period.
  • A non-cash impairment charge of $6.9 million decreased the U.S. Services segment's operating income by $0.09 per share.

Risks

  • The filing references risk factors detailed in the Annual Report on Form 10-K for the fiscal year ended September 30, 2025, and subsequent SEC filings.
  • Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those indicated.

Future Outlook

Maximus is raising its full fiscal year 2026 adjusted EBITDA margin guidance by 20 basis points to approximately 14.2% and increasing its adjusted diluted EPS guidance by $0.20 to a range of $8.25 to $8.55 per share. Revenue and free cash flow guidance for the full fiscal year 2026 remain reiterated at $5.2 billion to $5.35 billion and $450 million to $500 million, respectively.

Management Comments

  • "Our second consecutive earnings guidance increase reflects growing confidence in our ability to leverage in-house AI and other technology capabilities to improve efficiency and support margin expansion."
  • "We continue to execute our capital deployment strategy, as highlighted by the refresh of our share repurchase authorization up to an aggregate of $400 million."
  • "Our state customers are gaining clarity and beginning to take action to help address challenges with Medicaid community engagement, SNAP administration, and unemployment insurance support services. Were pleased to be playing a role in devising these solutions and expect momentum to continue to build."

Industry Context

StockSavvy.ai notes that Maximus's focus on leveraging AI and technology for efficiency gains aligns with broader trends in the government services sector, where agencies are increasingly seeking partners to modernize operations and improve service delivery amidst complex challenges.

Comparison to Industry Standards

  • The filing does not provide specific comparisons to industry benchmarks or competitors.
  • The company's net leverage ratio of 1.8x is stated to be within its target range of 2x to 3x, suggesting a conservative financial approach compared to some industry peers who may operate with higher leverage.

Stakeholder Impact

  • Shareholders: Benefit from increased earnings guidance, a $400 million share repurchase program, and a quarterly dividend of $0.33 per share.
  • Employees: Potential for improved efficiency and margin expansion may support continued investment in technology and operations.
  • Government Customers: Maximus is actively involved in devising solutions for challenges in Medicaid, SNAP, and unemployment insurance, indicating a supportive role in public service delivery.

Next Steps

  • Continue to execute capital deployment strategy with the refreshed share repurchase program.
  • Monitor and support state customers in addressing challenges with Medicaid, SNAP, and unemployment insurance.
  • Expect continued momentum in government service solutions.

Key Dates

DateDescription
March 31, 2026End of the second quarter of fiscal year 2026 and six-month period.
April 6, 2026Board of Directors declared a quarterly cash dividend.
May 1, 2026Additional share repurchases made through this date.
May 7, 2026Date of the report (Form 8-K filing) and press release announcing Q2 FY26 results.
May 11, 2026Effective date of the refreshed share repurchase program.
May 15, 2026Record date for the quarterly cash dividend.
June 1, 2026Payment date for the quarterly cash dividend.
September 30, 2025Fiscal year end for the referenced Annual Report on Form 10-K.

Recommendation

hold

The company has demonstrated operational improvements and is raising its earnings guidance, supported by a significant share repurchase program. However, the slight year-over-year revenue decline and the ongoing challenges in certain segments warrant a cautious 'hold' rating until sustained revenue growth is evident.

Keywords

Maximus, 8-K, Financial Results, Government Services, Earnings Outlook, Share Repurchase, EBITDA, EPS

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.